Japan is a front-runner when it comes to medtech and biotech innovations, and one organization that has reaped the benefit of this is world-leading 3D bioprinting company CELLINK, helmed by CEO Cecilia Edebo. She understands how Japan's fair and rule-based market creates a productive, promising, and forward-looking business environment where foreign businesses can maintain win-win relationships with collaborators and partners in innovative research fields. https://www.youtube.com/watch?v=YzR2FVs

How will #StemCell technology advance the development of a cure for neurodegenerative diseases like #ALS? Here's insight from the latest endeavor of a #bioengineering startup based in #Kawasaki City, Kanagawa Prefecture: https://lnky.jp/Dtl0jeJ #InnovationJapan #GlobalGoals | Japan - The Government of Japan